clofibrate has been researched along with Familial Combined Hyperlipidemia in 8 studies
angiokapsul: contains clofibrate & insoitolnicotinate
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized double blind, placebo-controlled crossover design was used to determine the efficacy of gemfibrozil and clofibrate in the treatment of familial combined hyperlipidemia and to determine which one of these agents would be more effective." | 9.06 | Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial. ( Frohlich, J; Hayden, M; Rabkin, SW, 1988) |
| "A randomized double blind, placebo-controlled crossover design was used to determine the efficacy of gemfibrozil and clofibrate in the treatment of familial combined hyperlipidemia and to determine which one of these agents would be more effective." | 5.06 | Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial. ( Frohlich, J; Hayden, M; Rabkin, SW, 1988) |
| "Oral carnitine has been reported to have a lipid-lowering effect with concomitant elevation of high density lipoprotein cholesterol (HDL-C) levels in normo- and hyperlipidemic individuals." | 1.27 | Plasma carnitine and lipid-lowering drugs. ( Davignon, J; Nestruck, AC; Pande, SV, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keen, H | 1 |
| Lewis, B | 1 |
| Miller, NE | 1 |
| Wynn, V | 1 |
| Davignon, J | 2 |
| Lipovetskiĭ, BM | 1 |
| Triufanov, VF | 1 |
| Konstantinov, VO | 1 |
| Raslová, K | 1 |
| Hucková, M | 1 |
| Rabkin, SW | 1 |
| Hayden, M | 1 |
| Frohlich, J | 1 |
| Gotto, AM | 1 |
| Jones, PH | 1 |
| Scott, LW | 1 |
| Brown, WV | 1 |
| Nestruck, AC | 1 |
| Pande, SV | 1 |
2 reviews available for clofibrate and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
[Diagnosis and treatment of primary hyperlipidemias].
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diagnosis, Differential; Drug Therapy, Combination; F | 1982 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibr | 1986 |
1 trial available for clofibrate and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial.
Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as To | 1988 |
5 other studies available for clofibrate and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Clofibrate and hyperlipidaemia.
Topics: Clofibrate; Diabetic Retinopathy; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Ty | 1980 |
[Drug therapy of hyperlipidemic states].
Topics: Adolescent; Adult; Cholestyramine Resin; Clofibrate; Drug Evaluation; Female; Humans; Hyperlipidemia | 1980 |
[Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia].
Topics: Apolipoproteins B; Blood Glucose; Clofibrate; Female; Humans; Hyperlipidemia, Familial Combined; Hyp | 1995 |
Potential use of fenofibrate and other fibric acid derivatives in the clinic.
Topics: Clofibrate; Fenofibrate; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hy | 1987 |
Plasma carnitine and lipid-lowering drugs.
Topics: Carnitine; Cholesterol, HDL; Clofibrate; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlip | 1985 |